(Q36918126)

17 August 2017

1 reference

title

Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies (English)

1 reference

17 August 2017

1 reference

2

Pierre Laurent-Puig

0 references

Jessica Zucman-Rossi

series ordinal

1

object named as

Jessica Zucman-Rossi

0 references

publication date

1 August 2007

1 reference

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

997-1003

1 reference

17 August 2017

8

1 reference

Tumors of the liver: Pathologic features

17 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Hepatitis B virus X protein: structure, function and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Bi-allelic inactivation of TCF1 in hepatic adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Genetics of hepatocellular tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

PTEN/MMAC1 mutations in hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Expression of vascular endothelial growth factor in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.8.997

21 January 2018

Identifiers

DOI

10.2217/14622416.8.8.997

1 reference

17 August 2017

1 reference

PubMed ID

17716233